Guiyang Xintian Pharmaceutical (002873.SZ) released its performance for the first three quarters, with a net income of 60.9998 million yuan, a year-on-year decrease of 30.45%.

Zhitong Finance · Oct 27 15:46

Guiyang Xintian Pharmaceutical (002873.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue...

Zhītōng Financial APP news, Guiyang Xintian Pharmaceutical (002873.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue of 0.661 billion yuan, a 14.80% decrease year-on-year. The net income attributable to the shareholders of the listed company was 60.9998 million yuan, a 30.45% decrease year-on-year. The net income attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 42.2651 million yuan, a 49.20% decrease year-on-year.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

新天药业(002873.SZ)发布前三季度业绩，净利润6099.98万元，同比下降30.45%

Guiyang Xintian Pharmaceutical (002873.SZ) released its performance for the first three quarters, with a net income of 60.9998 million yuan, a year-on-year decrease of 30.45%.

Risk Disclaimer

Statement